REVB Q1 2026 Earnings Significant EPS Miss as PreRevenue Biotech Reports Operating Loss HCM Q2 2023 Earnings Significant EPS Beat Driven by Operational Progress FTI Q1 2026 Earnings EPS Surpasses Estimates by Nearly 12 VIVS Q3 2025 Earnings EPS Beat Surprises Market Amid Challenging Environment AIRE Q1 2026 Earnings Narrowed Loss Exceeds Expectations Amid PreRevenue Phase KNSA Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Product Growth